Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

18.22 -0.24 (-1.30%)

Streaming Delayed Price Updated: 11:10 AM EDT, Aug 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	233,445
Open	18.70
Bid (Size)	18.21 (300)
Ask (Size)	18.23 (200)
Prev. Close	18.46
Today's Range	18.18 - 18.81
52wk Range	7.980 - 19.26
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

5 Insightful Analyst Questions From Amneal’s Q2 Earnings Call

Today 1:41 EDT

Amneal’s second quarter results reflected ongoing momentum driven by expanded product launches and strength across its core Affordable Medicines and Specialt...

Via StockStory

AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

July 31, 2026

Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 9.9% year on ...

Via StockStory

Performance

YTD	+43.9%	+43.9%
1 Month	+7.7%	+7.7%
3 Month	+33.8%	+33.8%
6 Month	+26.3%	+26.3%
1 Year	+124.1%	+124.1%

More News

Amneal (AMRX) Q2 2026 Earnings Call Transcript ↗

July 30, 2026

Via The Motley Fool

Amneal Pharmaceuticals (NASDAQ:AMRX) Soars on Q2 Earnings Beat and Raised Guidance ↗

July 30, 2026

Via Chartmill

Amneal Pharmaceuticals Q2 Earnings Call Highlights ↗

July 30, 2026

Via MarketBeat

Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

July 30, 2026

Via StockStory

Amneal Reports Second Quarter 2026 Financial Results

July 30, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings

July 28, 2026

Via StockStory

Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1

July 27, 2026

Via StockStory

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

July 23, 2026

From Kaskela Law LLC

Via Business Wire

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

July 17, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Reasons AMRX is Risky and 1 Stock to Buy Instead

July 15, 2026

Via StockStory

Amneal to Report Second Quarter 2026 Results on July 30, 2026

July 09, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

July 06, 2026

Via StockStory

1 Mooning Stock Worth Your Attention and 2 We Question

June 29, 2026

Via StockStory

1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky

June 17, 2026

Via StockStory

3 Russell 2000 Stocks with Open Questions

June 10, 2026

Via StockStory

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase ↗

June 09, 2026

Via MarketBeat

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

June 05, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Why Amneal (AMRX) Stock Is Trading Up Today

June 04, 2026

Via StockStory

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

June 04, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Profitable Stocks with Open Questions

June 04, 2026

Via StockStory

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

June 01, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

May 26, 2026

Via StockStory

2 Reasons AMRX is Risky and 1 Stock to Buy Instead

May 12, 2026

Via StockStory

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market

What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 18.22

When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 08/06/26 11:10 AM ET

What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 18.22K

How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Amneal Pharmaceuticals, Inc. - Class A Common Stock has 18K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.